Document is current
Any future updates will be listed below
-
Authors
Schlomberg, Jonas T. T.
Meling, Daniel
Grylka, Robin
Vasella, Emilia A.
Augustinovic, Dominik
Scheidegger, Milan
-
Funding
Funding for this research was provided by:
Digital Society Initiative, UZH
Fundação Bial (333/20)
Fundação Bial (333/20)
Reconnect Foundation
European Varela Award from Mind and Life Europe (# 2021EVA-Scheidegger, Milan)
- License Information
-
More Information
Article History
Received: 22 September 2025
Accepted: 4 February 2026
First Online: 18 March 2026
Competing interests
: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: JTTS, DM, RG, EV and DA report having no conflicts of interest with respect to research, authorship, and/or publication of this article. MS declares that he co-founded Reconnect Labs, an academic spin-off at the University of Zurich, focused on the development of psychedelic medicines for mental health.
